Peptide Longevity Q&A ·
Hexarelin has been shown to protect cardiac H9C2 cells from hypertrophy induced by angiotensin II. It enhances autophagy, reduces oxidative stress, and improves cell survival, suggesting a potential role in cardiac health during aging.
What the research shows
The study investigated the cardioprotective effects of Hexarelin on H9C2 cardiomyocytes subjected to hypertrophy via angiotensin II (Ang-II). The researchers measured autophagic markers, cell survival, apoptosis, and oxidative stress levels. They found that Hexarelin treatment significantly suppressed Ang-II-induced hypertrophy, oxidative stress, and apoptosis while enhancing autophagy in these cardiac cells.
Why it matters for longevity
The findings highlight the potential of Hexarelin as a therapeutic agent in combating cardiac hypertrophy, a condition prevalent in aging populations. By promoting autophagy and reducing oxidative stress, Hexarelin may contribute to improved cardiac function and overall heart health, which is crucial for longevity. Chronic cardiac conditions can lead to significant morbidity in older adults, making the understanding of such peptides vital for developing interventions aimed at enhancing healthspan.
Key findings at a glance
- Hexarelin protects H9C2 cardiomyocytes from Ang-II-induced hypertrophy.
- It enhances autophagy and improves cell survival in cardiac cells.
- Oxidative stress and apoptosis were significantly reduced with Hexarelin treatment.
- The peptide inhibits the phosphorylation of mTOR, a key regulator of autophagy.
- Inhibition of autophagy with 3-methyladenine negated the protective effects of Hexarelin.
How Hexarelin works (background)
Hexarelin is a synthetic growth hormone-releasing peptide that exerts cardioprotective effects through the modulation of autophagy. Autophagy is a cellular process that removes damaged organelles and proteins, promoting cellular health. The study found that Hexarelin enhances autophagic activity in H9C2 cells, which helps in mitigating the effects of hypertrophy induced by Ang-II. This process is linked to the inhibition of the mTOR signaling pathway, which is known to negatively regulate autophagy. By suppressing mTOR phosphorylation, Hexarelin facilitates autophagy, thereby contributing to improved cardiomyocyte health and function.
Safety, caveats, and what we don't yet know
While the research demonstrates promising results regarding Hexarelin's cardioprotective effects in H9C2 cells, it is important to note that these findings are preclinical. The study was conducted in vitro, and further research is needed to confirm these effects in vivo and in human populations. Additionally, the long-term safety and efficacy of Hexarelin in older adults or those with existing cardiac conditions remain to be established. Future studies should explore the broader implications of Hexarelin treatment across diverse age groups and health statuses.
Bottom line
Hexarelin shows potential as a protective agent against cardiac hypertrophy, enhancing autophagy and reducing oxidative stress. These findings may have implications for cardiac health in aging populations.
Related questions
Does Hexarelin reduce oxidative stress in aging cells?
Research indicates that Hexarelin reduces oxidative stress in H9C2 cardiomyocytes, which is important for maintaining cellular health and function, especially in aging populations.
Can Hexarelin improve heart function in older adults?
While Hexarelin has demonstrated cardioprotective effects in preclinical models, further research is needed to determine its efficacy in improving heart function in older adults.
What role does autophagy play in cardiac health?
Autophagy is crucial for cardiac health as it helps remove damaged cellular components. Enhancing autophagy may protect against cardiac hypertrophy and other age-related heart conditions.
Source: PubMed · Pharmazie · published 2019-08-01.